Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03149003
Title A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy (WIZARD201G)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Boston Biomedical, Inc
Indications

glioblastoma

Therapies

Bevacizumab + DSP-7888

Bevacizumab

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.